The United States Food and Drug Administration initiates the 510(k) clearance as a regulatory pathway to ensure that a particular medical device is safe and effective for its intended use. The US FDA uses this process to clear a device for commercial release. FDA 510(k) penetration testing for Medical Devices plays a crucial role in evaluating the security of these devices.
Cybersecurity is an activity that tries to impair unauthorized penetration, alteration, being put to inappropriate use, denial of service, or thwarting off unauthorized access to medical device information that has been stored, accessed, or sent to an outside recipient, according to the US FDA.
Medical devices are increasingly becoming networked. Consequently, it faces threats through cybersecurity attacks including hacking, data breaches, and malware attacks. Designing and developing security within medical devices can be important. Threats and vulnerabilities cannot be eliminated. Especially, there are significant difficulties in reducing the level of risks regarding cybersecurity. When organizations do not maintain cybersecurity correctly, they compromise device functionalities, lose personal or medical data, and increase the possibility of spreading threats to other connected networks or devices.
Cybersecurity incidents have made medical devices and hospital networks inoperative, thereby disrupting the delivery of patient care across healthcare facilities in the US. Such cyberattacks and exploits may also cause patients harm through clinical hazards, such as a delay in diagnosis and/or treatment of patients.
Incidents Caused by Compromised Cybersecurity
The following are some of the key incidents across the healthcare sector that emphasize the need for cybersecurity for patient safety:
- In 2017, the WannaCry ransomware attack impacted health centre structures and scientific devices around the sector.
- In 2020, a ransomware attack on one German health facility found eighty-three (eighty-three) feasible effects from delayed patient care, as the attack made patients rerouted to some other hospital.
“Explore: FDA Cybersecurity Guidelines for Medical Devices“
The Key Cybersecurity Considerations for the 510(k) Clearance
The FDA 510(k) penetration testing guidance is specific to pre-market submissions general principles of cybersecurity for medical device manufacturers are as follows:
- Quality System Regulation (QSR): As early as design and development are done, problems about cybersecurity ought to be managed to effectively and efficiently prevent patient hazards in the well-manufactured device. QSR requires each manufacturer to outline specific design inputs relative to security within the whole validation and the associated risk of its software component 21 CFR 820.30(g).
- Design Security: The devices need to be designed with device security in mind by the manufacturers of the products. The US FDA will judge the adequacy of the security on the ability of the device to provide and implement security objectives, such as authenticity, authorization, availability, confidentiality and security, and timely updating throughout the system architecture.
- Transparency: Adequate information does not exist to allow cybersecurity assurance of the equipment. That comprises information that enables the equipment to be integrated into an operational environment plus information the operators require for safety and cybersecurity within the lifespan of the equipment; thus, if there are adverse effects, device users will never know their significance. Therefore, users must obtain access to these cybersecurity controls concerning potential risks to them as users.
- Submitter Documentation: A device’s cyber security design and documentation should scale with the device’s cyber risk. Manufacturers need to consider a larger system for which a device may be deployed.
Challenge
One of our clients is a leading manufacturer of life-support devices. The client needed to navigate the FDA’s cybersecurity requirements for a next-generation ventilation system. Three major hurdles lay in their path:
- Regulatory Complexity: Translating cybersecurity efforts into FDA-compliant documentation.
- Validation Requirements: Proof of secure operation of all key components, including software and hardware.
- Time-to-market pressure to avoid late submissions and lost requirements.
What is an FDA 510(k) Submission?
Your 510(k) submission should demonstrate that your device is similar to a previously approved device and functions in a comparable manner. By aligning your device with a predicate device that is already in use and proven safe, it is expected that your device will also be safe and effective.
1. Your 510(k) submission must:
- Show that your medical device is similar to one already on the market.
- Provide technical, safety, and performance information in detail to prove its safety and effectiveness.
- Demonstrate that you have a good medical device quality and risk management system in place.
2. 510(k) Predicate Device
A predicate device is a device already marketed in the marketplace which your 510(k) submission must show to be very similar to your device.
The predicate device must have:
- The same purpose as your device.
- Technology such as this is applied to the functionality and functionality of your device.
- Equal degrees of safety and effectiveness as your device.
Your FDA 510(k) penetration testing submission must meet three important criteria. If your device belongs to Class II and does not have a substantial equivalent, you may need to pursue the de novo pathway, especially if it is a new and innovative medium-risk device. A successful 510(k) application requires a suitable predicate device as a reference.
Substantial equivalence does not mean it has to be similar; it’s a comparable device that shows competitive differentiation and advantage for your business. It requires finding the right balance, so make your decisions carefully.
Who Needs to Submit a 510(k)?
1. American Medical Device Manufacturers
The majority of 510(k) submissions are made by companies wishing to market Class II medical devices in the United States. If you are proposing to launch such a device, the person in charge of quality and regulation within your company would typically handle the 510(k) submission as part of the necessary steps to bring the product to market.
2. Representatives of Non-U.S. Manufacturers
The second largest volume of applicants according to the regulations of the FDA are appointed representatives of the manufacturer of the device, but originating from a source outside of the United States. Non-US makers who intend to sell their device in the US would have their designated representative apply for their 510(k).
3. Repadder/ Relbeller
In certain instances, a 510(k) application might be required by repackers and relabellers in a medical device supply chain. This often happens with special updates, where important changes are made, like adding new information to labels or making significant repackaging changes that affect the safety of the device.
Talk to our Cybersecurity Expert to discuss your specific needs and how we can help your business.
The FDA 510(k) Submission Process
1. Identifying Your Predicate Device
For an organization, it’s far critical to choose a predicate tool appropriately when they intend to file a 510(ok) application to the FDA. This is so because the 510(okay) method calls for the device to reveal significant equivalence to an already legally marketed predicate tool.
When a firm clears a device, it must be very close to the predicate device in use, indications for use, and technology. Added features or enhancements can be incorporated into the product but should not introduce new issues about safety or effectiveness. Not selecting an appropriate predicate device might make firms put more effort and resources into locating one.
2. Guidance and Software Considerations
It is also essential to examine any relevant special controls and guidance documents about the device being considered. These assist with giving advice on which tests and criteria must be met to demonstrate similarity to the predicate device. This is extremely helpful information that is often found in the predicate device’s 510(k) submission, which will detail tests and research performed, thus giving insight into the FDA expectations for your device.
When submitting a device with software, it is important to consider specific guidelines and risk classifications related to the software. The documentation needed for software will differ based on the software’s risk classification.
3. Clinical Data Inclusion
The FDA may request that clinical data be included in a 510(k) submission to show that any changes to its intended uses are in line with the original intended applications. Despite the best efforts of the FDA to clarify things through The 510(k) Program Guidance, there is sometimes disagreement between the agency and sponsors. This usually happens when the sponsors feel that non-clinical data would be sufficient to prove substantial equivalence, a view that the FDA often contests.
To improve this, the FDA has developed a draft guidance detailing when clinical data is necessary for a 510(k) submission. This does not only encompass the usual non-clinical data like bench performance or biocompatibility testing but also information from clinical studies.
4. Writing a Clear Submission
Medical device companies communicate through FDAs in collaboration before the submission of a 510(k) premarket notification. One must remember that the reviewers from the FDA may not know the intricacies of the device or the technology to the extent to which you would like them to have communicated to you. This calls for presenting simple and concise descriptions and complete background information along with relevant context.
Submission should be in very plain language that is understandable, not using technical terms or abbreviations not familiar to the FDA.
5. Submissions
The FDA has improved its submission process to be more electronic friendly. It introduced the Electronic Submission Template, effective in September 2022, and replaced this with the electronic submission instead of a paper copy. From this building block of success, the FDA stated in October 2022 that the Customer Collaboration Portal part of the CDRH accepts electronic submissions, including eCopy or eSTAR, for 510(k) submissions.
From October 1, 2023, it will be enough to submit just the eSTAR form. eSTAR is an electronic fillable PDF that will be submitted with the help of the CDRH Portal and requires registration on the portal. This new simplified process is towards the speedy submission of 510(k)s and simplification under the FDA’s initiative.
6. Wait
Although the goal is to approve devices within 100 days, the average approval time is 175 days. Some approvals take much longer, which skews the average higher, but the median approval time is 85 days.
The duration to clear a device through 510(k) varies by device category, with anesthesiology devices taking the longest at 245 days on average, while toxicology devices have the shortest approval time at 163 days. In summary, businesses can expect a waiting period of around 3-6 months after submission for device approval.
7. Clearance
The FDA does not ‘approve’ a medical device after an FDA 510(k) penetration testing submission. Instead, you will receive a letter saying that your device has been cleared for marketization in the United States. This clearance will allow you to market your device, but registration and listing, labelling, reporting, and GMP requirements according to FDA regulations will still apply.
Latest Penetration Testing Report
Conclusion
In summary, cybersecurity in medical devices is vital for patient safety and avoiding incidents that can interfere with healthcare delivery. The US FDA cybersecurity regulations compel manufacturers to address cybersecurity concerns as they design and develop medical devices and to be transparent about their cybersecurity controls.
The QSR, design security, transparency, and submission documentation are key considerations for the 510(k) clearance. One thing to discuss is common cybersecurity challenges like vulnerabilities in third-party components and ransomware attacks and implementing solutions like robust risk analysis and regular software updates.
Contact our Regulatory experts at Qualysec to experience a seamless FDA 510(k) penetration testing clearance process. Stay informed! Stay compliant!
0 Comments